News|Articles|September 14, 2025

Duchenne Action Month 2025: Looking Back at News and Expert Insights

In observance of Duchenne Action Month and World Duchenne Day, held annually in September, we took a look back at recent news in gene and cell therapy for DMD.

According to Parent Project Muscular Dystrophy, Duchenne muscular dystrophy, which causes progressive muscle weakness, constitutes the most common form of muscular dystrophy in children. The condition primarily affects boys, with around 1 in 5,000 boys currently living with DMD. Although no cure for DMD is available, a number of new transformative treatment options are currently under development or have recently reached commercialization.